1
Home
Companies

Bright Minds Biosciences

Bright Minds Biosciences
Leadership team

Mr. Ian McDonald (Co-Founder, CEO, Pres & Director)

Mr. Ryan E. S. K. Cheung B.Com., CA, CPA (Chief Financial Officer)

Dr. Jan Torleif Pedersen M.Sc., Ph.D. (Chief Science Officer & Director)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
0 - 50
Headquarters
Vancouver, British Columbia, Canada
Established
2017
Company Registration
SEC CIK number: 0001827401
Traded as
OTCQB:BMBIF
Social Media
URL
https://brightmindsbio.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Bright Minds Biosciences Inc., a biotechnology company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.
History

Bright Minds Biosciences was founded in 2019 by a group of scientists and engineers passionate about advancing the realm of neuroscience through innovative treatments.

Mission
Our mission is to develop treatments for neurological disorders that improve the quality of life of affected individuals.
Vision
Our vision is to create a world where neurological health is improved, so everyone can live their best lives. We are dedicated to creating products that not just improve lives, but save lives, too.
Key Team

Dr. Emer Leahy M.B.A., Ph.D. (Consultant)

Dr. Mark A. Smith M.D., Ph.D. (Chief Medical Officer)

Dr. Gideon Shapiro Ph.D. (VP of Discovery)

Recognition and Awards
Bright Minds Biosciences has received numerous awards, including the 2021 MIT Technology Review-Entrepreneur Top Innovator Award, the 2020 National Institutes of Health Grant, and the 2019 Breakthrough Prize in Life Sciences.
References

https://in.investing.com/equities/bright-minds-biosciences

https://finance.yahoo.com/quote/DRUG/profile?p=DRUG

https://www.crunchbase.com/organization/bright-minds-biosciences

https://brightmindsbio.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Bright Minds Biosciences
Leadership team

Mr. Ian McDonald (Co-Founder, CEO, Pres & Director)

Mr. Ryan E. S. K. Cheung B.Com., CA, CPA (Chief Financial Officer)

Dr. Jan Torleif Pedersen M.Sc., Ph.D. (Chief Science Officer & Director)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
0 - 50
Headquarters
Vancouver, British Columbia, Canada
Established
2017
Company Registration
SEC CIK number: 0001827401
Traded as
OTCQB:BMBIF
Social Media
URL
https://brightmindsbio.com